Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway - Luo, Xing; Duan, Yi; He, Jinwei; Huang, CongGai; Liu, Jun; Liu, Yifan; Xu, Mengdei; Dai, Qiong; Yang, Zhihui (Frontiers in Oncology, 2025)